Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 32% ± 15% | |
peripheral blood | 15 studies | 32% ± 11% | |
intestine | 10 studies | 28% ± 13% | |
kidney | 9 studies | 28% ± 9% | |
liver | 6 studies | 33% ± 17% | |
lymph node | 5 studies | 34% ± 8% | |
pancreas | 4 studies | 34% ± 11% | |
placenta | 4 studies | 26% ± 14% | |
bone marrow | 4 studies | 23% ± 3% | |
eye | 4 studies | 23% ± 5% | |
uterus | 4 studies | 36% ± 20% | |
breast | 4 studies | 25% ± 4% | |
brain | 4 studies | 26% ± 5% | |
adrenal gland | 3 studies | 28% ± 8% | |
thymus | 3 studies | 51% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3126.32 | 1445 / 1445 | 100% | 45.91 | 183 / 183 |
ovary | 100% | 3059.44 | 180 / 180 | 100% | 46.00 | 430 / 430 |
prostate | 100% | 3165.34 | 245 / 245 | 100% | 54.24 | 502 / 502 |
stomach | 100% | 2253.88 | 359 / 359 | 100% | 38.98 | 286 / 286 |
breast | 100% | 2864.86 | 459 / 459 | 100% | 50.81 | 1117 / 1118 |
intestine | 100% | 2910.55 | 966 / 966 | 100% | 38.48 | 526 / 527 |
lung | 100% | 2761.34 | 578 / 578 | 100% | 38.06 | 1152 / 1155 |
brain | 100% | 1734.29 | 2634 / 2642 | 100% | 40.06 | 705 / 705 |
pancreas | 100% | 1413.56 | 327 / 328 | 100% | 29.32 | 178 / 178 |
bladder | 100% | 3044.57 | 21 / 21 | 100% | 34.50 | 502 / 504 |
uterus | 100% | 3042.36 | 170 / 170 | 99% | 40.12 | 456 / 459 |
thymus | 100% | 3115.26 | 653 / 653 | 99% | 42.99 | 600 / 605 |
liver | 100% | 2612.72 | 226 / 226 | 98% | 27.86 | 397 / 406 |
kidney | 100% | 3424.47 | 89 / 89 | 97% | 28.96 | 874 / 901 |
skin | 100% | 3576.42 | 1809 / 1809 | 96% | 31.45 | 455 / 472 |
adrenal gland | 100% | 3052.24 | 258 / 258 | 91% | 22.56 | 209 / 230 |
adipose | 100% | 2696.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2913.33 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.04 | 29 / 29 |
muscle | 100% | 2658.50 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3105.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 45.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.65 | 1 / 1 |
heart | 99% | 2281.30 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2301.61 | 900 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 21.94 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_0036261 | Biological process | 7-methylguanosine cap hypermethylation |
GO_1903241 | Biological process | U2-type prespliceosome assembly |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006479 | Biological process | protein methylation |
GO_0008380 | Biological process | RNA splicing |
GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
GO_0005686 | Cellular component | U2 snRNP |
GO_0000243 | Cellular component | commitment complex |
GO_0005685 | Cellular component | U1 snRNP |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
GO_0005697 | Cellular component | telomerase holoenzyme complex |
GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
GO_0005683 | Cellular component | U7 snRNP |
GO_0034709 | Cellular component | methylosome |
GO_0034719 | Cellular component | SMN-Sm protein complex |
GO_0071011 | Cellular component | precatalytic spliceosome |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0097526 | Cellular component | spliceosomal tri-snRNP complex |
GO_0005684 | Cellular component | U2-type spliceosomal complex |
GO_0005682 | Cellular component | U5 snRNP |
GO_0005687 | Cellular component | U4 snRNP |
GO_0034715 | Cellular component | pICln-Sm protein complex |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0030532 | Cellular component | small nuclear ribonucleoprotein complex |
GO_0005689 | Cellular component | U12-type spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0071209 | Molecular function | U7 snRNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0071208 | Molecular function | histone pre-mRNA DCP binding |
GO_0070034 | Molecular function | telomerase RNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_1990446 | Molecular function | U1 snRNP binding |
Gene name | SNRPD3 |
Protein name | Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3) |
Synonyms | |
Description | FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome . Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes . As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs . As part of the U7 snRNP it is involved in histone pre-mRNA 3'-end processing (By similarity). . FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs. As part of the U7 snRNP it is involved in histone pre-mRNA 3'-end processing. . |
Accessions | P62318 H3BT13 ENST00000215829.8 [P62318-1] ENST00000439775.1 ENST00000402849.5 [P62318-2] |